NCT05557877View on ClinicalTrials.gov

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

January 30, 2027

Study Completion Date

January 30, 2027

Conditions
Breast Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood

DRUG

Low-Dose Aspirin

Given PO

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Biopsy

Undergo breast biopsy

Trial Locations (4)

46202

RECRUITING

Indiana University Simon Comprehensive Cancer Center, Indianapolis

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

32224-9980

SUSPENDED

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT05557877 - Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer | Biotech Hunter | Biotech Hunter